Results 81 to 90 of about 39,846 (186)

Efficacy of Dolutegravir Plus Lamivudine in People With TB/HIV Co‐Infection Using a Rifampicin or Rifabutin‐Based Regimen: A Retrospective Observational Case Series

open access: yesImmunity, Inflammation and Disease, Volume 14, Issue 3, March 2026.
ABSTRACT Introduction Co‐infection with tuberculosis (TB) is the leading cause of death in individuals infected with human immunodeficiency virus (HIV)‐1. Dolutegravir and lamivudine (DTG + 3TC) has recently been recommended as the preferred first‐line regimen for the treatment of new and treatment‐experienced HIV‐infected patients.
Jinhong He   +7 more
wiley   +1 more source

Current and emerging treatment strategies for Mycobacterium avium complex pulmonary disease: a narrative review [PDF]

open access: yesThe Ewha Medical Journal
The Mycobacterium avium complex (MAC), comprising M. avium and M. intracellulare, constitutes the predominant cause of nontuberculous mycobacterial pulmonary disease (NTM-PD) in Korea, followed by the M. abscessus complex.
Chiwook Chung
doaj   +1 more source

Combined Oral Contraceptive Drug–Drug Interaction Study With Ganfeborole, a New Anti‐Tuberculosis Agent

open access: yesThe Journal of Clinical Pharmacology, Volume 66, Issue 3, March 2026.
Abstract New drugs are urgently needed to treat drug‐resistant tuberculosis in combination regimens. Ganfeborole demonstrated bactericidal activity and good tolerability in clinical trials. In preclinical studies, ganfeborole showed embryofetal developmental effects, currently mandating highly effective non‐user dependent contraception in women of ...
Laura Iavarone   +13 more
wiley   +1 more source

Detection of Ethambutol-Resistant Associated Mutations in Mycobacterium tuberculosis Isolates from Iran Using Multiplex Allele-Specific PCR

open access: yesJournal of Medical Microbiology and Infectious Diseases, 2013
Tuberculosis is a serious global public health problem and its high prevalence is stron gly associated with the enhancement of drug resistance. In this study we demonstrate a multiplex allele-specific polymerase chain reaction (MAS)-PCR assay to ...
Somayeh Bahrami   +4 more
doaj  

Short-Course Chemotherapy for Tuberculosis [PDF]

open access: yes, 2005
Annotated and edite transcript of a Witness Seminar held on 3 February 2004. Introduction by Dr Linda Bryder, University of Auckland.First published by the Wellcome Trust Centre for the History of Medicine at UCL, 2005. ©The Trustee of the Wellcome Trust,
Christie, DA, Tansey, EM
core  

Fluoroquinolone Efficacy against Tuberculosis Is Driven by Penetration into Lesions and Activity against Resident Bacterial Populations. [PDF]

open access: yes, 2019
Fluoroquinolones represent the pillar of multidrug-resistant tuberculosis (MDR-TB) treatment, with moxifloxacin, levofloxacin, or gatifloxacin being prescribed to MDR-TB patients.
Alvarez-Cabrera, Nadine   +16 more
core   +2 more sources

Idiopathic AIDS enteropathy and treatment of gastrointestinal opportunistic pathogens. [PDF]

open access: yes, 2009
Diarrhea in patients with acquired immune deficiency syndrome (AIDS) has proven to be both a diagnostic and treatment challenge since the discovery of the human immunodeficiency virus (HIV) virus more than 30 years ago.
Cello, John P, Day, Lukejohn W
core  

Comparison of Mycobacterium tuberculosis drug susceptibility using solid and liquid culture in Nigeria. [PDF]

open access: yes, 2013
BACKGROUND: This study compares Mycobacterium tuberculosis culture isolation and drug sensitivity testing (DST) using solid (LJ) and liquid (BACTEC-MGIT-960) media in Nigeria.
Abdurrahman, Saddiq T   +9 more
core   +5 more sources

Rapidly developing Optic Neuritis secondary to Ethambutol: possible mechanism of injury [PDF]

open access: yes, 2005
Optic neuritis has been described among the toxic effects of Ethambutol. This side effect is dose related. The mean duration of Ethambutol induced optic neuritis (EON) is three months.
Ali, Sajjad   +2 more
core   +1 more source

Properties of Therapeutic Deep Eutectic Solvents of l-Arginine and Ethambutol for Tuberculosis Treatment

open access: yesMolecules, 2018
The treatment for tuberculosis infection usually involves a prolonged regimen of multiple antibacterial drugs, which might lead to various secondary effects.
Filipa Santos   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy